Endocrine System Diseases  >>  Cubicin (daptomycin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT01133600: Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens

Terminated
4
6
US
Cubicin, Vancomycin
Clinical Alliance for Research & Education - Infectious Diseases, LLC., Cubist Pharmaceuticals LLC
Diabetic Foot
08/12
08/12

Download Options